ProShare Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $264K | Sell |
|
|||||
|
2025
Q2 | $287K | Sell |
|
|||||
|
2025
Q1 | $320K | Sell |
|
|||||
|
2024
Q4 | $301K | Buy |
|
|||||
|
2024
Q3 | $185K | Buy |
|
|||||
|
2024
Q2 | $283K | Sell |
|
|||||
|
2024
Q1 | $364K | Buy |
|
|||||
|
2023
Q4 | $389K | Buy |
|
|||||
|
2023
Q3 | $306K | Sell |
|
|||||
|
2023
Q2 | $405K | Buy |
|
|||||
|
2023
Q1 | $397K | Sell |
|
|||||
|
2022
Q4 | $421K | Buy |
|
|||||
|
2022
Q3 | $534K | Buy |
|
|||||
|
2022
Q2 | $576K | Sell |
|
|||||
|
2022
Q1 | $1.1M | Sell |
|
|||||
|
2021
Q4 | $1.04M | Buy |
|
|||||
|
2021
Q3 | $909K | Sell |
|
|||||
|
2021
Q2 | $1.24M | Buy |
|
|||||
|
2021
Q1 | $1.31M | Buy |
|
|||||
|
2020
Q4 | $1.02M | Buy |
|
|||||
|
2020
Q3 | $770K | Sell |
|
|||||
|
2020
Q2 | $685K | Buy |
|
|||||
|
2020
Q1 | $296K | Sell |
|
|||||
|
2019
Q4 | $712K | Sell |
|
|||||
|
2019
Q3 | $645K | Buy |
|
|||||
|
2019
Q2 | $708K | Sell |
|
|||||
|
2019
Q1 | $698K | Buy |
|
|||||
|
2018
Q4 | $779K | Sell |
|
|||||
|
2018
Q3 | $1.06M | Sell |
|
|||||
|
2018
Q2 | $748K | Sell |
|
|||||
|
2018
Q1 | $777K | Sell |
|
|||||
|
2017
Q4 | $1.31M | Buy |
|
|||||
|
2017
Q3 | $991K | Buy |
|
|||||
|
2017
Q2 | $1.19M | Sell |
|
|||||
|
2017
Q1 | $1.14M | Sell |
|
|||||
|
2016
Q4 | $1M | Buy |
|
|||||
|
2016
Q3 | $964K | Sell |
|
|||||
|
2016
Q2 | $1.13M | Buy |
|
|||||
|
2016
Q1 | $1.73M | Sell |
|
|||||
|
2015
Q4 | $2.78M | Buy |
|
|||||
|
2015
Q3 | $1.35M | Sell |
|
|||||
|
2015
Q2 | $2.52M | Sell |
|
|||||
|
2015
Q1 | $3.37M | Buy |
|
|||||
|
2014
Q4 | $2.96M | Sell |
|
|||||
|
2014
Q3 | $3.28M | Sell |
|
|||||
|
2014
Q2 | $3.58M | Sell |
|
|||||
|
2014
Q1 | $3.76M | Buy |
|
|||||
|
2013
Q4 | $964K | Sell |
|
|||||
|
2013
Q3 | $1.4M | Buy |
|
|||||
|
2013
Q2 | $531K | Buy |
|